TCL Archive NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel October 17, 1980
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003